The United States authorizes the antiviral remdesivir against the Covid-19

Remdesivir -

The U.S. Medicines Agency on Thursday granted full authorization for the antiviral drug remdesivir for hospital patients with the coronavirus, confirming the conditional authorization granted in May, according to its manufacturer Gilead.

Gilead announced that it had received authorization for the drug, under the Veklury brand, stressing that it was the only specific treatment against Covid-19 thus authorized after a more rigorous and definitive verification procedure.

However, other treatments have received authorizations for emergency use.

Gilead's stock on the New York Stock Exchange jumped 4% soon after the announcement.

Health

Coronavirus: European Union signs contract with United States for 500,000 doses of remdesivir

Science

Coronavirus: Clinical trial of experimental treatment similar to that received by Trump suspended

• United States

• Covid 19

• Coronavirus

• Health

• World